Most of the brain’s nerve cells are made before birth, but a small number of new ones can still appear later in life.
New research suggests that this limited production of fresh brain cells may be important for protecting adults against major depression.
The study was led by researchers at Columbia University Vagelos College of Physicians and Surgeons. It was published on August 21, 2026, in Nature Medicine under the title ‘Dysregulated adult hippocampal neurogenesis in major depressive disorders.’
The researchers focused on the hippocampus, a part of the brain that helps people form memories and connect those memories with emotions. The hippocampus is also one of the few brain areas where new neurons can continue to develop during adulthood.
For many years, depression was often explained mainly as a problem involving brain chemicals such as serotonin. Scientists now believe the condition is much more complex and may involve changes in brain circuits, stress responses, inflammation, gene activity, and the ability of nerve cells to adapt.
The new study adds another piece to that picture. The researchers found evidence that the normal production of new neurons in the adult hippocampus appears to slow or stall in people with major depressive disorder.
That finding matters because new neurons may help the brain keep similar experiences separate from one another. This ability is important for memory and may also influence how people understand emotional events in daily life.
Imagine having lunch with a friend who seems quiet because she is tired. A healthy memory system may store that event as a single experience, but a less flexible system may blend it with older memories of rejection and make the moment feel more negative than it really is.
Scientists call this process pattern separation. It allows the brain to tell the difference between events that share some features but are not actually the same.
Animal research has already shown that new neuron growth in the hippocampus is important for pattern separation. Studies involving people whose hippocampus was exposed to radiation have also suggested that reduced production of new neurons may affect similar memory functions in humans.
The Columbia team wanted to look directly at what was happening inside the brains of people who had experienced depression. They examined nearly half a million individual brain cells collected after death from people with major depression and from people without the disorder.
Using newer laboratory methods, the researchers measured which genes were active in individual cells and looked for changes in proteins. This allowed them to study not only whether cells were different, but also where those differences appeared within the hippocampus.
The results went well beyond the creation of new neurons. The researchers found changes in genes involved in forming connections between brain cells, sending signals, producing energy, and moving materials inside cells.
They also found signs of inflammation and cellular stress in a major hippocampal pathway that helps create new memories with emotional meaning. This suggests that depression may affect a wider brain system rather than a single chemical or cell type.
Some of the altered genes had already been linked to depression through earlier genetic studies. Other genes showed changes in the way they were switched on or off, which may reflect the effects of life experiences such as stress, aging, learning, or environmental exposures.
These findings may help explain why depression can look so different from one person to another. One person may mainly experience sadness, while another may struggle more with memory, motivation, sleep, anxiety, or a strong tendency to expect negative outcomes.
The researchers believe that future treatments might try to restore healthy neuron growth in the hippocampus. In theory, increasing the brain’s ability to make and use new neurons could improve memory flexibility and make it easier to separate present experiences from painful memories from the past.
However, this idea is still at an early stage. The study shows a strong biological connection between depression and reduced adult neuron growth, but it does not prove that stalled neuron production is the single cause of depression or that simply increasing neuron growth would cure the condition.
The work also supports a broader idea that major depression may include several different biological subtypes. The Columbia researchers hope that one day depression could be classified by patterns in genes, cells, and brain circuits, much as some cancers are now divided into molecular types.
This study is important because it moves the discussion of depression beyond a simple shortage of one brain chemical. Its strength lies in the unusually detailed look at individual human brain cells, but the findings came from brain tissue collected after death, so they cannot show exactly when the changes began or how they developed over time.
Overall, the results provide some of the clearest evidence so far that reduced creation of new neurons may be part of major depression in adults. The study does not yet offer a new treatment, but it gives researchers several new targets to investigate and may eventually help doctors match different types of depression with more precise treatments.
Source: Columbia University.
